Package Label.Principal Display Panel
NDC 70771-1598-6
Oseltamivir Phosphate for Oral Suspension
6 mg/mL *
60 mL (usable volume after constitution)
Mfg Label (396be9cc Cc64 4337 Adf3 52339dd7f2ba 01)
Oseltamivir Phosphate Suspension
FDA Label NDC 70771-1598
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Oseltamivir Phosphate (NDC 70771-1598). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
* Please review the disclaimer below.
